Velan Inc. (TSE:VLN - Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$14.85 and traded as low as C$14.10. Velan shares last traded at C$14.11, with a volume of 2,502 shares.
Velan Stock Performance
The company has a debt-to-equity ratio of 21.78, a current ratio of 1.34 and a quick ratio of 1.11. The firm has a market capitalization of C$207.50 million, a P/E ratio of -3.26 and a beta of 0.77. The stock's 50 day moving average is C$15.33 and its two-hundred day moving average is C$14.85.
Velan Company Profile
(
Get Free Report)
Velan Inc is an international manufacturer of industrial valves. It offers products such as Gate valves, check valves, cryogenic, steam traps, and others, which are used in various industries including power generation, oil, and gas, refining and petrochemicals, chemical, liquid natural gas (LNG) and cryogenics, pulp and paper, geothermal processes and shipbuilding.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Velan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Velan wasn't on the list.
While Velan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
